1 terminated, 1 unknown. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Cyclooxygenase 1: new trials by email Literature Review of Cyclooxygenase 1 trials Research Report on Cyclooxygenase 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis Cox-2, Indomethacin - Pancreatitis, Acute | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 2700 | 2016-12-01 | 2016-11-16 |
| Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT radiation therapy, Celecoxib - Brain and Central Nervous System Tumors | Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 35 | 2003-10-01 | 2015-03-18 |
Central Nervous System Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Pancreatitis (1)
First Affiliated Hospital Xi'an Jiaotong University (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (1)
U01CA062475 (1)